228.74MMarket Cap
LossP/E TTM
PRQR Financials
See ProQR Therapeutics NV's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
ProQR Therapeutics NV Earnings Date
Latest Release
May 12, 2026
EPS / Forecast
-0.11/-0.10
Revenue / Forecast
1.73M/4.51M
Revenue(YoY)
18.82M
-11.29%
Analyst Rating
BUY
2026/08/02
FAQs
What is the total revenue of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its total revenue reached 18.82M, with a year-on-year change of 21.21M.
What are the current assets of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its current assets were 115.24M, with a year-on-year change of -30.97.
What are the total assets of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its total assets of ProQR Therapeutics NV were 129.78M, with a year-on-year change of -28.80.
What are the total liabilities of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its total liabilities of ProQR Therapeutics NV were 72.95M, with a year-on-year change of -15.33.
What is the total equity of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its total equity of ProQR Therapeutics NV was 56.83M, with a year-on-year change of -40.87.
What is the net operating income of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its net operating income of ProQR Therapeutics NV was -50.01M, with a year-on-year change of -51.22.
What is the net investment of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its net investment of ProQR Therapeutics NV was -1.17M, with a year-on-year change of 73.44.
What is the net financing of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its net financing of ProQR Therapeutics NV was -2.11M, with a year-on-year change of -102.77.
What is the Earnings Per Share (EPS) of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its Earnings Per Share (EPS) was -0.47, with a year-on-year change of -40.88.
What is the net income of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its net income was -48.55M, with a year-on-year change of -61.16.
What is the net margin of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its net profit margin was -258.05, with a year-on-year change of -81.67.
What is the debt-to-asset ratio of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its debt-to-asset ratio was 14.16, with a year-on-year change of 38.12.
What is the Return on Equity (ROE) of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its Return on Equity (ROE) was -61.17, with a year-on-year change of -43.15.
What is the Return on Assets (ROA) of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its Return on Assets (ROA) was -30.05, with a year-on-year change of -65.54.
What is the operating profit of ProQR Therapeutics NV?
According to ProQR Therapeutics NV's FY2025 earnings report, its operating profit was -50.01M, with a year-on-year change of -51.22.